Increased iron and ferritin content of sputum from patients with cystic fibrosis or chronic bronchitis

Chest

Volumn 114, Issue 3, 1998, Pages 814-819

  Stites, Steve W ^a   Walters, Brian ^b   O'Brien Ladner, Amy R ^b   Bailey, Kirstin ^b   Wesselius, Lewis J ^b  

^a UNIVERSITY OF KANSAS MEDICAL CENTER   (United States)

^b NONE

Author keywords

Chronic bronchitis; Cystic fibrosis; Ferritin; Iron; Sputum

Indexed keywords

FERRITIN; IRON; TRANSFERRIN;

ADULT; AGED; ARTICLE; CHRONIC BRONCHITIS; CLINICAL ARTICLE; COLORIMETRY; CONTROLLED STUDY; CYSTIC FIBROSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN CELL; MALE; PRIORITY JOURNAL; RADIOIMMUNOASSAY; RESPIRATORY TRACT INFLAMMATION; SPUTUM ANALYSIS;

EID: 0031687134     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.114.3.814     Document Type: Article

References (29)

1. Halliwell B, Gutteridge JMC. Oxygen free radicals and iron in relation to biology and medicine: some problems and concepts. Arch Biochem Biophys 1986; 246:501-514
2. Wesselius LJ, Nelson ME, Skikne BS. Increased release of ferritin and iron by iron-loaded alveolar macrophages in cigarettes smokers. Am J Respir Crit Care Med 1994; 150: 690-695
3. Stites SW, Nelson ME, Wesselius LJ. Transferrin concentrations in serum and lower respiratory tract fluid of mechanically ventilated patients with COPD or ARDS. Chest 1995; 107:1681-1685
4. Herbert V, Shaw S, Jayatilleke E, et al. Most free-radical injury is iron-related: it is promoted by iron, hemin, holoferritin and vitamin C, and inhibited by desferoxamine and apoferritin. Stem Cells 1994; 12:289-303
5. Reif DW. Ferritin as a source of iron for oxidative damage. Free Radic Biol Med 1992; 12:417-427
6. Gutteridge JMC, Quilan GJ. Antioxidant protection against organic and inorganic oxygen radicals by normal human plasma: the important primary role for iron-binding and iron-oxidizing proteins. Biochim Biophys Acta 1992; 1159: 248-254
7. Mills PC, Roberts CA, Smith NC. Effects of ozone and airway inflammation on glutathione status and iron homeostasis in the lungs of horses. Am J Vet Res 1996; 57:1359-1363
8. Romling U, Fiedler B, Bosshammer J, et al. Epidemiology of chronic Pseudomonas aeruginosa infections in cystic fibrosis. J Infect Dis 1994; 170:1616-1621
9. Ward CG, Bullen JJ, Rogers HJ. Iron and infection: new developments and their implications. J Trauma 1996; 41:356-364
10. Jackson S, Morris BC. Enhancement of growth of Pasteurella pestis and other bacteria in serum by the addition of iron. Br J Exp Pathol 1961; 42:363-369
11. Bullen JJ, Wark CG, Wallis SN. Virulence and the role of iron in Pseudomonas aeruginosa infection. Infect Immun 1974; 10:443-450
12. American Thoracic Society. Statement by the Committee on Diagnostic Standards for Nontuberculous Respiratory Diseases: definitions and classification of chronic bronchitis, asthma and pulmonary emphysema. Am Rev Respir Dis 1962; 85:762-768
13. Pizzichini MM, Popov TA, Efthimiadis A, et al. Spontaneous and induced sputum to measure indices of airway inflammation in asthma. Am J Respir Crit Care Med 1996; 154:866-869
14. Richman-Eisenstat JBY, Jorens PG, Hebert CA, et al. Interleukin-8: an important chemoattractant in sputum of patients with chronic inflammatory airway diseases. Am J Physiol 1993; 264(Lung Cell Mol Physiol 8):L413-418
15. Skikne BS. A commercial electrochemical method evaluated for measurement of iron status. Clin Chem 1987; 33:1645-1647
16. Buindi ME, Skikne BS, Lowell AM, et al. An immunoassay for human transferrin. Am J Clin Nutr 1988; 47:37-41
17. Wesselius LJ, Flowers CH, Skikne BS. Alveolar macrophage content of isoferritins and transferrin. Am Rev Respir Dis 1992; 145:311-316
18. Summers M, Worwood M, Jacobs A. Ferritin in normal erythrocytes, lymphocytes, polymorhs and monocytes. Br J Haematol 1974; 28:19-26
19. Halliwell B, Gutteridge JMC. Biologically relevant metal ion-dependent hydroxyl radical generation. FEBS Lett 1992; 307:108-112
20. Witko-Sarsat V, Delacourt C, Rabier D, et al. Neutrophil-derived long-lived oxidants in cystic fibrosis sputum. Am J Respir Crit Care Med 1995; 152:1910-1916
21. Misawa M, Aral H. Airway inflammation induced by xanthine/ xanthine oxidase in guinea pigs. Agents Actions 1993; 38: 19-26
22. Muntane J, Puig-Parellada P, Mitjavila MT. Iron metabolism and oxidative stress during acute and chronic phases of experimental inflammation: effect of iron-dextran and deferoxamine. J Lab Clin Med 1995; 126:435-443
23. Folkesson HG, Westrom BR, Pierzynowski SG, et al. Lung to blood passage of different-sized molecules during lung inflammation in the rat. J Appl Physiol 1991; 71:1106-1111
24. Britigan BE, Rasmussen GT, Cox CD. Augmentation of oxidant injury to human pulmonary epithelial cells by the Pseudomonas aeruginosa siderophore pyochelin. Infect Immun 1997; 65:1071-1076
25. Romero A, Perez-Arellano JL, Gonzalez-Villaron G, et al. Effect of transferrin concentrations on bacterial growth in human ascitic fluid from cirrhotic and nephrotic patients. Eur J Clin Invest 1993; 23:699-705
26. Schuster A, Haarmann A, Wahn V. Cytokines in neutrophil-dominated airway inflammation in patients with cystic fibrosis. Eur Arch Otorhinolaryngol 1995; 252(suppl 1):S59-S60
27. Fahmy M, Young SP. Modulation of iron metabolism in monocyte cell line U937 by inflammatory cytokines: changes in transferrin uptake, iron handling and ferritin mRNA. Biochem J 1993; 296:175-181
28. Britigan BE, Hayek MB, Doebbeling BN, et al. Transferrin and lactoferrin undergo proteolytic cleavage in the Pseudomonas aeruginosa-infected lungs of patients with cystic fibrosis. Infect Immun 1993; 61:5049-5055
29. Britigan BE, Edeker BL. Pseudomonas and neutrophil products modify transferrin and lactorferrin to create conditions that favor hydroxyl radical formation. J Clin Invest 1991; 88:1092-1102